Lipid rafts are subdomains of the cell membrane with distinct protein composition and high concentrations of cholesterol and glycosphingolipids. Raft proteins are thought to mediate diverse cellular processes including signal transduction. However, its cellular mechanisms remain unclear. Caveolin-1 (cav-1, marker protein of caveolae) has been thought as a switchboard between extracellular matrix (ECM) stimuli and intracellular signals. Flotillin-2/reggie-1(Flot-2) is another ubiquitously expressed raft protein which defines non-caveolar raft microdomains (planar raft). Its cellular function is largely uncharacterized. Our novel studies demonstrated that Flot-2, in conjunction with cav-1, played important functions on controlling cell death via regulating Fas pathways. Using Beas2B epithelial cells, we found that in contrast to cav-1, Flot-2 conferred cytoprotection via preventing Fas mediated death-inducing signaling complex (DISC) formation, subsequently suppressed caspase-8 mediated extrinsic apoptosis. Moreover, Flot-2 reduced the mitochondria mediated intrinsic apoptosis by regulating the Bcl-2 family and suppressing cytochrome C release from mitochondria to cytosol. Flot-2 further modulated the common apoptosis pathway and inhibited caspase-3 activation via up-regulating the members in the inhibitor of apoptosis (IAP) family. Last, Flot-2 interacted with cav-1 and limited its expression. Taken together, we found that Flot-2 protected cells from Fas induced apoptosis and counterbalanced the pro-apoptotic effects of cav-1. Thus, Flot-2 played crucial functions in cellular homeostasis and cell survival, suggesting a differential role of individual raft proteins.
References
[1]
Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555–556.
[2]
Wyllie AH (1986) What is apoptosis? Histopathology 10: 995–998.
[3]
Fiers W, Beyaert R, Declercq W, Vandenabeele P (1999) More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 18: 7719–7730.
[4]
Vercammen D, Brouckaert G, Denecker G, Van de Craen M, Declercq W, et al. (1998) Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med 188: 919–930.
[5]
Lemaire C, Andreau K, Souvannavong V, Adam A (1998) Inhibition of caspase activity induces a switch from apoptosis to necrosis. FEBS Lett 425: 266–270.
[6]
Li-Weber M, Krammer PH (2003) Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system. Semin Immunol 15: 145–157.
[7]
Denecker G, Vercammen D, Declercq W, Vandenabeele P (2001) Apoptotic and necrotic cell death induced by death domain receptors. Cell Mol Life Sci 58: 356–370.
[8]
Algeciras-Schimnich A, Pietras EM, Barnhart BC, Legembre P, Vijayan S, et al. (2003) Two CD95 tumor classes with different sensitivities to antitumor drugs. Proc Natl Acad Sci U S A 100: 11445–11450.
[9]
Barnhart BC, Alappat EC, Peter ME (2003) The CD95 type I/type II model. Semin Immunol 15: 185–193.
[10]
Wang X, Ryter SW, Dai C, Tang ZL, Watkins SC, et al. (2003) Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway. J Biol Chem 278: 29184–29191.
[11]
Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, et al. (1995) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270: 7795–7798.
[12]
Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM (1995) FADD, a novel death domain containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505–512.
[13]
Siegel RM, Chan FK, Chun HJ, Lenardo MJ (2000) The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 1: 469–474.
[14]
Peter ME, Krammer PH (2003) The CD95 (APO-1/Fas) DISC and beyond. Cell Death Differ 10: 26–35.
[15]
Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495–516.
[16]
Cande C, Cohen I, Daugas E, Ravagnan L, Larochette N, et al. (2002) Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria. Biochimie 84: 215–222.
[17]
Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, et al. (2004) Toxic proteins released from mitochondria in cell death. Oncogene 23: 2861–2874.
[18]
Eguchi Y, Shimizu S, Tsujimoto Y (1997) Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 57: 1835–1840.
[19]
Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P (1997) Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 185: 1481–1486.
[20]
Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, et al. (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364: 806–809.
[21]
Lee PJ, Choi AM (2003) Pathways of cell signaling in hyperoxia. Free Radic Biol Med 35: 341–350.
[22]
Matsumura H, Shimizu Y, Ohsawa Y, Kawahara A, Uchiyama Y, et al. (2000) Necrotic death pathway in Fas receptor signaling. J Cell Biol 151: 1247–1256.
[23]
Camhi SL, Lee P, Choi AM (1995) The oxidative stress response. New Horiz 3: 170–182.
[24]
Gajate C, Mollinedo F (2001) The antitumor ether lipid ET-18-OCH(3) induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells. Blood 98: 3860–3863.
[25]
Gajate C, Gonzalez-Camacho F, Mollinedo F (2009) Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells. PLOS ONE 4: e5004.
[26]
Zhang M, Lee SJ, An C, Xu JF, Joshi B, et al. (2011) Caveolin-1 mediates Fas-BID signaling in hyperoxia-induced apoptosis. Free Radic Biol Med 50: 1252–1262.
[27]
Chen ZH, Lam HC, Jin Y, Kim HP, Cao J, et al. (2010) Autophagy protein microtubule-associated protein 1 light chain-3B (LC3B) activates extrinsic apoptosis during cigarette smoke-induced emphysema. Proc Natl Acad Sci U S A 107: 18880–18885.
[28]
Wang XQ, Paller AS (2006) Lipid rafts: membrane triage centers. J Invest Dermatol 126: 951–953.
[29]
Langhorst MF, Reuter A, Jaeger FA, Wippich FM, Luxenhofer G, et al. (2008) Trafficking of the microdomain scaffolding protein reggie-1/flotillin-2. Eur J Cell Biol 87: 211–226.
[30]
Zhao F, Zhang J, Liu YS, Li L, He YL (2011) Research advances on flotillins. Virol J 8 479: 36.
[31]
Budinger GR, Mutlu GM, Urich D, Soberanes S, Buccellato LJ, et al. (2011) Epithelial cell death is an important contributor to oxidant-mediated acute lung injury. Am J Respir Crit Care Med 183: 1043–1054.
[32]
Yerbes R, Palacios C, Reginato MJ, Lopez-Rivas A (2011) Cellular FLIP(L) plays a survival role and regulates morphogenesis in breast epithelial cells. Biochim Biophys Acta 1813: 168–178.
[33]
Yang YL, Li XM (2000) The IAP family: endogenous caspase inhibitors with multiple biological activities. Cell Res 10: 169–177.
[34]
Rajalingam K, Oswald M, Gottschalk K, Rudel T (2007) Smac/DIABLO is required for effector caspase activation during apoptosis in human cells. Apoptosis 12: 1503–1510.
[35]
Eramo A, Sargiacomo M, Ricci-Vitiani L, Todaro M, Stassi G, et al. (2004) CD95 death-inducing signaling complex formation and internalization occur in lipid rafts of type I and type II cells. Eur J Immunol 34: 1930–1940.
[36]
Zhu XD, Zhuang Y, Ben JJ, Qian LL, Huang HP, et al. (2011) Caveolae-dependent endocytosis is required for class A macrophage scavenger receptor-mediated apoptosis in macrophages. J Biol Chem 286: 8231–8239.
[37]
Park EK, Park MJ, Lee SH, Li YC, Kim J, et al. (2009) Cholesterol depletion induces anoikis-like apoptosis via FAK down-regulation and caveolae internalization. J Pathol 218: 337–349.
[38]
Guo YH, Hernandez I, Isermann B, Kang TB, Medved L, et al. (2009) Caveolin-1-dependent apoptosis induced by fibrin degradation products. Blood 113: 4431–4439.
[39]
Zhao X, Liu Y, Ma Q, Wang X, Jin H, et al.. (2009) Caveolin-1 negatively regulates TRAILinduced apoptosis in human hepatocarcinoma cells. Biochem Biophys Res Commun 378: 21– 26.
[40]
Newman GR, Campbell L, von Ruhland C, Jasani B, Gumbleton M (1999) Caveolin and its cellular and subcellular immunolocalisation in lung alveolar epithelium: implications for alveolar epithelial type I cell function. Cell Tissue Res 295: 111–120.
[41]
Li WP, Liu P, Pilcher BK, Anderson RG (2001) Cell-specific targeting of caveolin-1 to caveolae, secretory vesicles, cytoplasm or mitochondria. J Cell Sci 114: 1397–1408.
[42]
Aoki T, Normura R, Fujimoto T (1999) Tyrosine phosphorylation of caveolin-1 in the endothelium. Exp Cell Res 253(2): 629–36.
[43]
Zhang M, Lin L, Lee SJ, Mo L, Cao J, et al. (2009) Deletion of caveolin-1 protects hyperoxia induced apoptosis via survivin mediated pathways. . Am J Physiol Lung Cell Mol Physiol. 297(5): L945–53.
[44]
Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, et al. (2010) Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation. Cell Cycle 9: 2201–2219.
[45]
Mollinedo F, Fernández M, Hornillos V, Delgado J, Amat-Guerri F, et al. (2011) Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria. . Cell Death Dis. 19: 2: e158.
[46]
Morrow IC, Rea S, Martin S, Prior IA, Prohaska R, et al. (2002) Flotillin-1/reggie-2 traffics to surface raft domains via a novel golgi-independent pathway. Identification of a novel membrane targeting domain and a role for palmitoylation. J Biol Chem 13: 48834–48841.
[47]
Fernow I, Icking A, Tikkanen R (2007) Reggie-1 and reggie-2 localize in non-caveolar rafts in epithelial cells: cellular localization is not dependent on the expression of caveolin proteins. Eur J Cell Biol 86: 345–352.
[48]
Rajendran L, Le Lay S, Illges H (2007) Raft association and lipid droplet targeting of flotillins are independent of caveolin. Biol Chem 388: 307–314.
[49]
Volonte D, McTiernan CF, Drab M, Kasper M, Galbiati F (2008) Caveolin-1 and caveolin-3 form heterooligomeric complexes in atrial cardiac myocytes that are required for doxorubicininduced apoptosis. Am J Physiol Heart Circ Physiol 294: H392–401.
[50]
Ding Y, Jiang M, Jiang W, Su Y, Zhou H, et al. (2005) Expression, purification, and characterization of recombinant human flotillin-1 in Escherichia coli. Protein Expr Purif 42: 137–145.
